These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35835860)

  • 21. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
    Choksi TT; Zhang H; Chen T; Malhotra N
    Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials.
    Guo QH; Zhu ZM; Feng YQ; Lin JX; Wang JG
    J Clin Hypertens (Greenwich); 2023 Mar; 25(3):227-237. PubMed ID: 36756690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing Hypertension Using Combination Therapy.
    Smith DK; Lennon RP; Carlsgaard PB
    Am Fam Physician; 2020 Mar; 101(6):341-349. PubMed ID: 32163253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice.
    Veronesi M; Cicero AF; Prandin MG; Dormi A; Cosentino E; Strocchi E; Borghi C
    Vasc Health Risk Manag; 2007; 3(6):999-1005. PubMed ID: 18200818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in blood pressure control in hypertensive patients with diabetes mellitus in Japan.
    Hirose H; Saito I
    Hypertens Res; 2003 Sep; 26(9):717-22. PubMed ID: 14620927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study.
    Ahmed M; Alanbaei M; El Tamimi H; Al-Wahshi Y; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(6):570-575. PubMed ID: 27456109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
    Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the treatment of hypertension in diabetes mellitus: a need for better control?
    Sequeira RP; Al Khaja KA; Damanhori AH
    J Eval Clin Pract; 2004 Feb; 10(1):107-16. PubMed ID: 14731158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly?
    Kaiser EA; Lotze U; Schäfer HH
    Clin Interv Aging; 2014; 9():459-75. PubMed ID: 24711696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).
    Hsieh MS; How CK; Hsieh VC; Chen PC
    Shock; 2020 Apr; 53(4):407-415. PubMed ID: 31135703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of antihypertensive drugs in nondiabetic patients with hypertension: A population-based study.
    Machado MAÁ; de Moura CS; Wang Y; Danieli C; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Clin Hypertens (Greenwich); 2017 Oct; 19(10):999-1009. PubMed ID: 28755451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive drug treatment changes in the general population: the CoLaus study.
    Christe V; Waeber G; Vollenweider P; Marques-Vidal P
    BMC Pharmacol Toxicol; 2014 Mar; 15():20. PubMed ID: 24685255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines.
    Egan BM; Yang J; Rakotz MK; Sutherland SE; Jamerson KA; Wright JT; Ferdinand KC; Wozniak GD
    Hypertension; 2022 Feb; 79(2):338-348. PubMed ID: 34784722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
    Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
    Marott SC; Nielsen SF; Benn M; Nordestgaard BG
    Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.